In Vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: Varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 95 (6) , 1334-1341
- https://doi.org/10.1002/jps.20538
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Whatever happened to cassette-dosing pharmacokinetics?Drug Discovery Today, 2004
- Effective Dosing Regimen of 1-Aminobenzotriazole for Inhibition of Antipyrine Clearance in Rats, Dogs, and MonkeysDrug Metabolism and Disposition, 2002
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- QSAR Model for Drug Human Oral BioavailabilityJournal of Medicinal Chemistry, 2000
- Pharmacokinetics and metabolism in early drug discoveryCurrent Opinion in Chemical Biology, 1999
- Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.Pharmaceutical Research, 1999
- Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extractionAdvanced Drug Delivery Reviews, 1997
- Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by RifampinHepatology, 1996
- First-pass metabolism of midazolam by the human intestine*Clinical Pharmacology & Therapeutics, 1995
- First-pass metabolism of cyclosporin by the gutThe Lancet, 1991